Cytotoxic chemotherapy for cancer in Felty's syndrome: role of lithium carbonate.
A 61-yr-old white man with Felty's syndrome, who had previously undergone splenectomy, presented for cytotoxic chemotherapy. Random granulocyte counts remained low, prohibiting the initiation of such treatment. A trial of lithium carbonate was instituted, resulting in prompt elevation of granulocyte counts into the normal range. Cytotoxic chemotherapy was then administered, and fluctuations of neutrophil counts similar to those of hematologically normal individuals were observed.
D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications; D005258:Felty Syndrome / Q000150:complications*; D006801:Humans; D007958:Leukocyte Count; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000150:complications; D009504:Neutrophils; D013163:Splenomegaly / Q000150:complications; D013274:Stomach Neoplasms / Q000150:complications / Q000188:drug therapy*
D000970:Antineoplastic Agents; D016651:Lithium Carbonate; D008094:Lithium